Genentech

• Growth Checkup

  February 24, 2012

• High Hopes and Altered Genes

  By Kenneth Silber, Research  |  October 1, 2009

  Biotech has long been a high-risk, high-reward industry. It is an industry in which numerous firms, including many small-caps and start-ups, intensively research possible...

• The Right Remedies

  By Janet Levaux, AdvisorOne  |  September 1, 2009

  Research's Health Care Guide: Beckman Coulter Inc. (BEC) Roche Holding AG (RHHBY) Watson Pharmaceuticals Inc. (WPI) --- Karen Andersen,...

• Biotech/Health Care Investing: Selective Growth

  By Janet Levaux, AdvisorOne  |  March 1, 2009

  --- Alexandra Hauber J.P. Morgan 312-325-3694 Alexandra.m.hauber@jpmorgan.com We expect currency to have a significant impact on 2009 earnings. The biggest effect, due to the British pound weakness, is likely at...

• What's Up, Doc?

  By Staff writer  |  December 1, 2000

  Faraz Naqvi, Manager and M.D., uses his varied exp